<!DOCTYPE html>
<html>
  <head>
    <title>Lymphoma</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/haematology/">haematology</a></li>
      <li class="active">Lymphoma</li>
  </ol>

  <div class="page-header">
 
    <h1>Lymphoma</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Lymphoma</strong></a>
          <div class="toc">
<ul>
<li><a href="#differential-diagnosis-of-cervical-ln-enlargement">Differential diagnosis of cervical LN enlargement</a></li>
<li><a href="#hodgkins-lymphoma">Hodgkin’s lymphoma</a></li>
<li><a href="#non-hodkins-lymphoma">non-Hodkin’s lymphoma</a><ul>
<li><a href="#follicular-lymphoma">Follicular lymphoma</a></li>
<li><a href="#diffuse-large-b-cell-lymphoma">Diffuse large B cell lymphoma</a></li>
<li><a href="#burkitts-lymphoma">Burkitt’s lymphoma</a></li>
<li><a href="#t-cell-lymphoma">T-cell lymphoma</a></li>
</ul>
</li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <blockquote>
<p>commoner compared to leukaemia</p>
<p>incraseing in incidence</p>
<p>mostly characterised by lymphomatous growth</p>
<p>primary extranodal in 20% NHL</p>
<p>classified on basis of histological appearance</p>
</blockquote>
<h3 id="differential-diagnosis-of-cervical-ln-enlargement">Differential diagnosis of cervical LN enlargement</h3>
<ul>
<li>
<p>Infections</p>
<ul>
<li>
<p>acute</p>
<ul>
<li>
<p>pyogenic infections</p>
</li>
<li>
<p>EBV</p>
</li>
<li>
<p>toxoplasmosis</p>
</li>
<li>
<p>CMV</p>
</li>
<li>
<p>infected eczema</p>
</li>
<li>
<p>cat scratch fever</p>
</li>
<li>
<p>viral…</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>chronnic</p>
<ul>
<li>
<p>Tb</p>
</li>
<li>
<p>syphilis</p>
</li>
<li>
<p>sarcoidosis</p>
</li>
<li>
<p>HIV</p>
</li>
</ul>
</li>
<li>
<p>Autoimmune</p>
<ul>
<li>RA</li>
</ul>
</li>
<li>
<p>Drug reactions</p>
<ul>
<li>Phenytoin</li>
</ul>
</li>
<li>
<p>Primary lymph node malignancies</p>
</li>
<li>
<p>Secondary malignancy</p>
</li>
<li>
<p>Kawasaki syndrome</p>
</li>
</ul>
<h3 id="hodgkins-lymphoma">Hodgkin’s lymphoma</h3>
<ul>
<li>
<p>rare disease</p>
</li>
<li>
<p>3 / 100 000</p>
</li>
<li>
<p>M>F</p>
</li>
<li>
<p>epidemological data - links EBV with HL</p>
</li>
<li>
<p>Reed-Sternberg cell in lymph node biopsy</p>
<ul>
<li>usually B-cells but occ. T cells (periphery)</li>
</ul>
</li>
<li>
<p>symptoms / signs</p>
<ul>
<li>
<p>Lymph node enlargement</p>
</li>
<li>
<p>hepatoplenomegaly</p>
</li>
<li>
<p>systemic “B” symptoms</p>
</li>
<li>
<p>other constitutional symptoms</p>
<ul>
<li>
<p>pruritis</p>
</li>
<li>
<p>fatigue</p>
</li>
<li>
<p>anorexia</p>
</li>
</ul>
</li>
<li>
<p>etoh induced pain at site of enlarged lymp nodes</p>
<ul>
<li>symptoms due to involvement of other organs</li>
</ul>
</li>
</ul>
</li>
<li>
<p>investigations</p>
<ul>
<li>
<p>LN biopsy</p>
</li>
<li>
<p>blood count</p>
</li>
<li>
<p>ESR</p>
<ul>
<li>indicator of disease activity</li>
</ul>
</li>
<li>
<p>LFTs</p>
</li>
<li>
<p>lactaate dehydrongenase (LDH)</p>
<ul>
<li>raised = adverse prognostic factor</li>
</ul>
</li>
<li>
<p>uric acid</p>
</li>
<li>
<p>CXR</p>
</li>
<li>
<p>BM aspirate/trephine</p>
</li>
</ul>
</li>
</ul>
<h3 id="non-hodkins-lymphoma">non-Hodkin’s lymphoma</h3>
<ul>
<li>
<p>most (70%) of b-cell origin</p>
</li>
<li>
<p>30% T-cell origin</p>
</li>
<li>
<p>associated with EBV 10-30% of tumours</p>
</li>
<li>
<p>clinical features</p>
<ul>
<li>
<p>peripheral lymphaedeonpathy</p>
</li>
<li>
<p>systemic symptoms</p>
</li>
<li>
<p>extranodal presentation</p>
<ul>
<li>
<p>more common compared to HL</p>
</li>
<li>
<p>abdominal = hepatosplenomegaly</p>
</li>
<li>
<p>skin = </p>
<ul>
<li>
<p>mycosis fungoides</p>
<ul>
<li>
<p>T-cell lymphoma</p>
</li>
<li>
<p><a href="http://www.dermnetnz.org/dermal-infiltrative/cutaneous-t-cell-lymphoma.html">dermnet</a></p>
</li>
</ul>
</li>
<li>
<p>Sezary syndrome</p>
<ul>
<li>AKA redman syndrome</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>prognostic factors:</p>
<ul>
<li>
<p>age >60</p>
</li>
<li>
<p>advanced disease</p>
</li>
<li>
<p>High serum LDH</p>
</li>
<li>
<p>ECOG 2></p>
</li>
<li>
<p>more than one extranodal site involvement</p>
</li>
</ul>
</li>
<li>
<p>most common AIDS defining malignancy</p>
<ul>
<li>Burkitt’s </li>
</ul>
</li>
</ul>
<h4 id="follicular-lymphoma">Follicular lymphoma</h4>
<ul>
<li>
<p>20%</p>
</li>
<li>
<p>most present feeling well</p>
</li>
<li>
<p>remitting and recurring disease</p>
</li>
</ul>
<h4 id="diffuse-large-b-cell-lymphoma">Diffuse large B cell lymphoma</h4>
<ul>
<li>
<p>most common</p>
</li>
<li>
<p>almost invariably fatal without therapy within months</p>
</li>
<li>
<p>>50% young people cured</p>
</li>
<li>
<p>CHOP + R</p>
</li>
</ul>
<h4 id="burkitts-lymphoma">Burkitt’s lymphoma</h4>
<ul>
<li>
<p>uncommon lymphoma in western world</p>
</li>
<li>
<p>endemic to afriva - mosquito belt</p>
</li>
<li>
<p>Close association to EBV</p>
</li>
<li>
<p>very high proliferative index</p>
<ul>
<li>rapidly fatal</li>
</ul>
</li>
<li>
<p>clincial presentation = lymphadenopathy</p>
</li>
<li>
<p>CNS involvement common</p>
</li>
</ul>
<h4 id="t-cell-lymphoma">T-cell lymphoma</h4>
<ul>
<li>
<p>much less common than b-cell </p>
</li>
<li></li>
</ul>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
